UBS AM’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-266,443
| Closed | -$236K | – | 2750 |
|
|
2022
Q4 | $236K | Hold |
266,443
| – | – | ﹤0.01% | 2400 |
|
|
2022
Q3 | $418K | Hold |
266,443
| – | – | ﹤0.01% | 2406 |
|
|
2022
Q2 | $536K | Buy |
266,443
+10,100
| +4% | +$20.3K | ﹤0.01% | 2279 |
|
|
2022
Q1 | $597K | Hold |
256,343
| – | – | ﹤0.01% | 2391 |
|
|
2021
Q4 | $1.19M | Sell |
256,343
-45,555
| -15% | -$212K | ﹤0.01% | 2117 |
|
|
2021
Q3 | $2.3M | Sell |
301,898
-8,403
| -3% | -$64.1K | ﹤0.01% | 1772 |
|
|
2021
Q2 | $3.01M | Buy |
310,301
+81,402
| +36% | +$789K | ﹤0.01% | 1661 |
|
|
2021
Q1 | $1.89M | Buy |
228,899
+8,883
| +4% | +$73.5K | ﹤0.01% | 1764 |
|
|
2020
Q4 | $1.5M | Buy |
220,016
+98,990
| +82% | +$676K | ﹤0.01% | 1800 |
|
|
2020
Q3 | $1.35M | Buy |
121,026
+5,543
| +5% | +$61.8K | ﹤0.01% | 1717 |
|
|
2020
Q2 | $725K | Buy |
+115,483
| New | +$725K | ﹤0.01% | 1940 |
|
|
2019
Q4 | – | Sell |
-48,801
| Closed | -$104K | – | 2908 |
|
|
2019
Q3 | $104K | Sell |
48,801
-4,095
| -8% | -$8.76K | ﹤0.01% | 2658 |
|
|
2019
Q2 | $141K | Buy |
52,896
+14,943
| +39% | +$39.9K | ﹤0.01% | 2608 |
|
|
2019
Q1 | $180K | Buy |
37,953
+3,900
| +11% | +$18.5K | ﹤0.01% | 2490 |
|
|
2018
Q4 | $81.7K | Buy |
34,053
+12,453
| +58% | +$29.9K | ﹤0.01% | 2535 |
|
|
2018
Q3 | $95K | Hold |
21,600
| – | – | ﹤0.01% | 2531 |
|
|
2018
Q2 | $156K | Buy |
+21,600
| New | +$156K | ﹤0.01% | 2523 |
|